Appointment of Alternate Director Mediclinic International plc (the “Company”) (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 Appointment of Alternate Director The Board of Mediclinic International plc is pleased to announce that as of 7 April 2016, Mr Jannie Durand, a non-executive director of the Company, has appointed Mr Pieter Uys as his alternate director. Since 2013, Mr Uys has held the position of Head of Strategic Investment at Remgro Limited, a Johannesburg Stock Exchange listed investment company with meaningful interests in a number of businesses across the world. Prior to joining Remgro, Mr Uys was a founding member and ultimately became the CEO of Vodacom Group, one of the leading mobile networks in Africa. Mr Uys holds a MEng (Electrical) and an MBA from the University of Stellenbosch, South Africa. There is no further information to be disclosed in accordance with Listing Rule 9.6. Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom Website: www.mediclinic.com JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd For further information, please contact: Company Secretary Victoria Dalby Capita Company Secretarial Services Limited +44 (0)207 954 9528 8 April 2016 Date: 08/04/2016 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.